Auxiliary Discrminator Sequence Generative Adversarial Networks (ADSeqGAN) for Few Sample Molecule Generation

• URL: http://arxiv.org/abs/2502.16446v2
• Date: Thu, 11 Sep 2025 19:05:03 GMT
• Title: Auxiliary Discrminator Sequence Generative Adversarial Networks (ADSeqGAN) for Few Sample Molecule Generation
• Authors: Haocheng Tang, Jing Long, Beihong Ji, Junmei Wang,
• Abstract summary: Auxiliary Discriminator Sequence Generative Adversarial Networks (ADSeqGAN) is a novel approach for molecular generation in small-sample datasets.<n>Our method incorporates pretrained generator and Wasserstein distance to enhance training stability and diversity.
• Score: 1.8502648146670078
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: In this work, we introduce Auxiliary Discriminator Sequence Generative Adversarial Networks (ADSeqGAN), a novel approach for molecular generation in small-sample datasets. Traditional generative models often struggle with limited training data, particularly in drug discovery, where molecular datasets for specific therapeutic targets, such as nucleic acids binders and central nervous system (CNS) drugs, are scarce. ADSeqGAN addresses this challenge by integrating an auxiliary random forest classifier as an additional discriminator into the GAN framework, significantly improves molecular generation quality and class specificity. Our method incorporates pretrained generator and Wasserstein distance to enhance training stability and diversity. We evaluate ADSeqGAN across three representative cases. First, on nucleic acid- and protein-targeting molecules, ADSeqGAN shows superior capability in generating nucleic acid binders compared to baseline models. Second, through oversampling, it markedly improves CNS drug generation, achieving higher yields than traditional de novo models. Third, in cannabinoid receptor type 1 (CB1) ligand design, ADSeqGAN generates novel druglike molecules, with 32.8\% predicted actives surpassing hit rates of CB1-focused and general-purpose libraries when assessed by a target-specific LRIP-SF scoring function. Overall, ADSeqGAN offers a versatile framework for molecular design in data-scarce scenarios, with demonstrated applications in nucleic acid binders, CNS drugs, and CB1 ligands.

Related papers

• Transcriptome-Conditioned Personalized De Novo Drug Generation for AML Using Metaheuristic Assembly and Target-Driven Filtering [0.0]
  Acute Myeloid Leukemia (AML) remains a clinical challenge due to its extreme molecular heterogeneity and high relapse rates.<n>This paper presents a novel, end-to-end computational framework that bridges the gap between patient-specific transcriptomics and de novo drug discovery.
  arXiv  Detail & Related papers  (2025-12-24T17:39:37Z)
• QCA-MolGAN: Quantum Circuit Associative Molecular GAN with Multi-Agent Reinforcement Learning [2.2463678997251604]
  This work presents a novel quantum circuit Born machine (QCBM)-enabled Generative Adrialversa Network (GAN), called QCA-MolGAN, for generating drug-like molecules.<n>QCBM serves as a learnable prior distribution, which is associatively trained to define a latent space aligning with high-level features captured by the GANs discriminator.<n>We integrate a novel multi-agent reinforcement learning network to guide molecular generation with desired targeted properties.
  arXiv  Detail & Related papers  (2025-09-05T12:31:58Z)
• Generative molecule evolution using 3D pharmacophore for efficient Structure-Based Drug Design [8.652951659846838]
  We propose an evolutionary framework named MEVO, which bridges the gap between billion-scale small molecule dataset and the scarce protein-ligand complex dataset.<n>MEVO is composed of three key components: a high-fidelity VQ-VAE for molecule representation in latent space, a diffusion model for pharmacophore-guided molecule generation, and a pocket-aware evolutionary strategy for molecule optimization.
  arXiv  Detail & Related papers  (2025-07-27T04:58:11Z)
• A Reinforcement Learning-Driven Transformer GAN for Molecular Generation [6.397243531623856]
  This study introduces RL-MolGAN, a novel Transformer-based discrete GAN framework designed to address these challenges. Unlike traditional Transformer, RL-MolGAN utilizes a first-decoder-then-encoder structure, facilitating the generation of drug-like molecules from both $denovo$ and scaffold-based designs. In addition, RL-MolGAN integrates reinforcement learning (RL) and Monte Carlo tree search (MCTS) techniques to enhance the stability of GAN training and optimize the chemical properties of the generated molecules.
  arXiv  Detail & Related papers  (2025-03-17T04:06:10Z)
• UniGenX: Unified Generation of Sequence and Structure with Autoregressive Diffusion [61.690978792873196]
  Existing approaches rely on either autoregressive sequence models or diffusion models. We propose UniGenX, a unified framework that combines autoregressive next-token prediction with conditional diffusion models. We validate the effectiveness of UniGenX on material and small molecule generation tasks.
  arXiv  Detail & Related papers  (2025-03-09T16:43:07Z)
• Dumpling GNN: Hybrid GNN Enables Better ADC Payload Activity Prediction Based on Chemical Structure [53.76752789814785]
  DumplingGNN is a hybrid Graph Neural Network architecture specifically designed for predicting ADC payload activity based on chemical structure. We evaluate it on a comprehensive ADC payload dataset focusing on DNA Topoisomerase I inhibitors. It demonstrates exceptional accuracy (91.48%), sensitivity (95.08%), and specificity (97.54%) on our specialized ADC payload dataset.
  arXiv  Detail & Related papers  (2024-09-23T17:11:04Z)
• Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
  AliDiff is a novel framework to align pretrained target diffusion models with preferred functional properties. It can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score.
  arXiv  Detail & Related papers  (2024-07-01T06:10:29Z)
• TAGMol: Target-Aware Gradient-guided Molecule Generation [19.977071499171903]
  3D generative models have shown significant promise in structure-based drug design (SBDD) We decouple the problem into molecular generation and property prediction. The latter synergistically guides the diffusion sampling process, facilitating guided diffusion and resulting in the creation of meaningful molecules with the desired properties. We call this guided molecular generation process as TAGMol.
  arXiv  Detail & Related papers  (2024-06-03T14:43:54Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• Latent Chemical Space Searching for Plug-in Multi-objective Molecule Generation [9.442146563809953]
  We develop a versatile 'plug-in' molecular generation model that incorporates objectives related to target affinity, drug-likeness, and synthesizability. We identify PSO-ENP as the optimal variant for multi-objective molecular generation and optimization.
  arXiv  Detail & Related papers  (2024-04-10T02:37:24Z)
• Molecular De Novo Design through Transformer-based Reinforcement Learning [38.803770968809225]
  We introduce a method to fine-tune a Transformer-based generative model for molecular de novo design. Our proposed method exhibits superior performance in generating compounds predicted to be active against various biological targets. Our approach can be used for scaffold hopping, library expansion starting from a single molecule, and generating compounds with high predicted activity against biological targets.
  arXiv  Detail & Related papers  (2023-10-09T02:51:01Z)
• Energy-based Generative Models for Target-specific Drug Discovery [7.509129971169722]
  We develop an energy-based probabilistic model for computational target-specific drug discovery. Results show that our proposed TagMol can generate molecules with similar binding affinity scores as real molecules.
  arXiv  Detail & Related papers  (2022-12-05T16:41:36Z)
• Tailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design [133.1268990638971]
  De novo drug design based on the structure of a target protein can provide novel drug candidates. We present a generative solution named TamGent that can directly generate candidate drugs from scratch for a given target.
  arXiv  Detail & Related papers  (2022-08-30T09:32:39Z)
• Retrieval-based Controllable Molecule Generation [63.44583084888342]
  We propose a new retrieval-based framework for controllable molecule generation. We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria. Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
  arXiv  Detail & Related papers  (2022-08-23T17:01:16Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)
• Evening the Score: Targeting SARS-CoV-2 Protease Inhibition in Graph Generative Models for Therapeutic Candidates [11.853524110656991]
  We look at the therapeutic design of novel drug candidates targeting SARS-CoV-2 viral proteins. We use an autoencoder that generates molecules with similar structures to a dataset of drugs with anti-SARS activity. During generation, we explore optimization toward several design targets to balance druglikeness, synthetic accessability, and anti-SARS activity.
  arXiv  Detail & Related papers  (2021-05-07T18:39:25Z)
• Benchmarking Deep Graph Generative Models for Optimizing New Drug Molecules for COVID-19 [11.853524110656991]
  Design of new drug compounds with target properties is a key area of research in generative modeling. We present a small drug molecule design pipeline based on graph-generative models and a comparison study of two state-of-the-art graph generative models for designing COVID-19 targeted drug candidates.
  arXiv  Detail & Related papers  (2021-02-09T17:49:26Z)
• CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models [74.58583689523999]
  We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins. CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme. CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
  arXiv  Detail & Related papers  (2020-04-02T18:17:20Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.